Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 2, 1998, Pages 382-395

  Carroll, Paul V ^a   Christ, Emanuel R ^a   Bengtsson, B A ^a   Carlsson, L ^a   Christiansen, J S ^a   Clemmons, D ^a   Hintz, R ^a   Ho, K ^a   Laron, Z ^a   Sizonenko, P ^a   Sonksen P H ^a   Tanaka, T ^a   Thorner, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; RECOMBINANT GROWTH HORMONE;

ACROMEGALY; ARTHRALGIA; BODY COMPOSITION; BONE DENSITY; BONE METABOLISM; CARPAL TUNNEL SYNDROME; CONTROLLED STUDY; EDEMA; ENCEPHALOCELE; GROWTH HORMONE DEFICIENCY; GYNECOMASTIA; HEADACHE; HEART ARRHYTHMIA; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INTRACRANIAL HYPERTENSION; MUSCLE STRENGTH; PAPILLEDEMA; PRIORITY JOURNAL; REVIEW; TINNITUS;

EID: 2142673373     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.2.4594     Document Type: Review

References (165)

1. Sönksen PH. 1990 Replacement therapy in hypothalamo-pituitary insufficiency after childhood: management in the adult. Horm Res. 33(Suppl 4):45-51.
2. Rosen T, Bengtsson B-Å. 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:285-288.
3. Raben MS. 1962 Clinical use of human growth hormone. N Engl J Med. 266:82-86.
4. Bates AS, Van't Hoff W, Jones PJ, Clayton RN. 1996 The effect of hyopituitarism on life expectancy. J Clin Endocrinol Metab. 81:1169-1172.
5. Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnston DG, Foale RA. 1992 Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J 67:92-96.
6. Salomon F, Cuneo RD, Hesp R, Sönksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
7. Jorgensen JOL, Pedersen SA, Thuesen L, et al. 1989 Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1:1221-1225.
8. Davidson MB. 1987 Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev. 8:115-131.
9. Press M. 1988 Growth hormone and metabolism. Diabetes Metab Rev. 4:391-414.
10. Ikkos D, Luft R, Gemzell CA. 1959 The effect of human growth hormone in man. Acta Endocrinol (Copenh). 32:341-361.
11. De Boer H, Blok GJ, van der Veen VA. 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev. 16:63-86.
12. Bengtsson BA, Eden S, Lonn L, et al. 1993 Treatment of adults with growth hormone deficiency with recombinant human GH. J Clin Endocrinol Metab. 76:309-317.
13. Snel YE, Doerga ME, Brummer RM, Zelissen PM, Koppeschaar HP. 1995 Magnetic resonance imaging-assessed adipose tissue and serum lipid and insulin concentrations in growth hormone-deficient adults. Effect of growth hormone replacement. Arterioscler Thromb Vasc Biol. 15:1543-1548.
14. Whitehead HM, Boreham C, McIlrath EM, et al. 1992 Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf). 36:45-52.
15. Binnerts A, Swart GR, Wilson JHP, et al. 1992 The effect of growth hormone administration in growth hormone deficient daults on bone, protein, carbohydrate and lipid homeostasis, as well as body composition. Clin Endocrinol (Oxf). 37:79-87.
16. Chong PKK, Jung RT, Scrimgeour CM, Rennie MJ, Paterson CR. 1994 Energy expenditure and body composition in growth hormone deficient adults on exogenous growth hormone. Clin Endocrinol (Oxf). 40:103-110.
17. Snel YE, Doerga ME, Brummer RJ, Zelissen PM, Zonderland ML, Koppeschaar HP. 1995 Resting metabolic rate, body composition and related hormonal parameters in growth hormone-deficient adults before and after growth hormone replacement therapy. Eur J Endocrinol. 133:445-450.
18. Hoffman DM, O'Sullivan AJ, Freund J, Ho KK. 1995 Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. J Clin Endocrinol Metab. 80:72-77.
19. Beshyah SA, Freemantle C, Thomas E, et al. 1995 Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin Endocrinol (Oxf). 42:179-189.
20. Rosen T, Bosaeus I, Tolli J, Lindstedt G, Bengtsson BA. 1993 Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol (Oxf). 38:63-71.
21. Amato G, Carella C, Fazio S, et al. 1993 Body composition, bone metabolism, and heart structure and function in growth hormone-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab. 77:1671-1676.
22. De Boer H, Blok GJ, Voerman HJ, De Vries PM, van der Veen EA. 1992 Body composition in adult growth deficient men assessed by anthropometry and bioimpedance analysis. Clin Endocrinol Metab. 75:833-837.
23. De Boer H, Blok GJ, Voerman B, de Vries P, Popp-Snijders C, van der Veen E. 1995 The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis. J Clin Endocrinol Metab. 80:2069-2076.
24. Moller J, Frandsen E, Fisker S, Jorgensen JOL, Christiansen JS. 1996 Decreased plasma and extracellular volume in growth hormone-deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study. Clin Endocrinol (Oxf). 44:533-539.
25. Christ ER, Cummings MH, Pearson TC, Sönksen PH, Russell-Jones DL. 1997 Effects of growth hormone deficiency on plasma volume and red cell mass. Endocrinol Metab. 4(Suppl)A:60.
26. Johansson G, Rosen T, Lindstedt G, Bosaeus I, Bengtsson BA. 1996 Effect of 2 years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency. Endocrinol Metab. 4(Suppl A):3-12.
27. Orme SM, Sebastian JP, Oldroyd B, et al. 1992 Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy. Clin Endocrinol (Oxf). 37:453-59.
28. Jorgensen JOL, Thuesen L, Muller J, et al. 1994 Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. Eur J Endocrinol. 130:224-28.
29. Beshyah SA, Freemantle C, Shahi M, et al. 1995 Replacement therapy with biosynthestic human growth hormone in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf). 42:73-81.
30. Lonn L, Johansson G, Sjostrom L, Kvist H, Oden A, Bengtsson BA. 1996 Body composition and tissue distributions in growth hormone deficient adults before and after growth hormone treatment. Obes Res. 4:45-54.
31. Hansen TB, Vahl N, Jorgensen JO, Christiansen JS, Hagen C. 1995 Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study. Clin Endocrinol. 43:689-696.
32. Baum HB, Biller BM, Finkelstein JS, et al. 1996 Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset of growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med. 125:883-890.
33. Attanasio AF, Lamberts SWJ, Matranga AMC, et al. 1997 Adult growth hormone-deficient patients demonstrate heterogenity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab. 82:82-88.
34. Herlitz H, Jonsson O, Bengtsson BA. 1994 Effect of recombinant human growth hormone on cellular sodium metabolism. Clin Sci. 86:233-237.
35. Christ E, Cummings MH, Westwood NB, et al. The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency. J Clin Endocrinol Metab. In press.
36. Hoffman DM, Crampton L, Sernia C, Nguyen TV, Ho KKY. 1996 Short term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure. J Clin Endocrinol Metab. 81:1123-1128.
37. Wüster CHR, Slenczka E, Ziegler R. 1991 Increased prevalence of osteoporosis and arteriosclerosis in patients with conventionally substituted pituitary insufficiency: is there a need for additional growth hormone substitution? Klin Wochenschr. 69:769-773.
38. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, et al. 1996 Increased fracture rate in adults with growth hormone deficiency. Endocrinol Metab. 3(Suppl A):121.
39. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM. 1993 Increased bone density after recombinant human growth hormone therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab. 76:1344-1348.
40. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. 1992 Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary insuficiencies of childhood onset. J Clin Endocrinol Metab. 74:118-123.
41. Hyer SL, Rodin DA, Tobias JH, Leiper A, Nussey SS. 1992 Growth hormone deficiency during puberty reduces adult bone mineral density. Arch Dis Child. 67:1472-1474.
42. De Boer H, Blok GJ, Van Lingen A, Teule GJJ, Lips P, Van Der Veen EA. 1994 Consequences of of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res. 9:1319-1326.
43. Johannsson AG, Burman P, Westermark K, Ljunghall S. 1992 The bone mineral density in acquired growth hormone deficiency correlates with circulating insulin-like growth factor. J Intern Med. 232:447-452.
44. Bing-You RG, Denis MC, Rosen CJ. 1993 Low bone mineral density in adults with previous hypothalamic-pituitary tumors; correlation with GH responses to GHRH, IGF-I and IGFBP-3. Calcif Tissue Int. 52:183-187.
45. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. 1994 Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab. 78:669-674.
46. Rosen T, Hansson T, Granhed H, Szucs J, Bengtsson BA. 1995 Reduced bone mineral content in adult patients with growth hormone deficiency. Eur J Endocrinol. 132:727-729.
47. Thoren M, Soop M, Degerblad M, Saaf M. 1993 Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adult growth hormone deficiency. Acta Endocrinol (Copenh). 128(Suppl 2):41-43.
48. Degerblad M, Bengtsson BA, Bramnert M, et al. 1995 Reduced bone mineral density in adults with growth hormone deficiency: increased bone turnover during 12 months of GH substitution. Eur J Endocrinol. 133:180-188.
49. Nielsen HK, Jorgensen JOL, Brixen K, Christiansen JS. 1991 Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: dose-response studies with biosynthetic human GH. Calcif Tissue Int. 46:82-87.
50. Johannsen JS, Pedersen SA, Jorgensen JOL, et al. 1990 Effects of growth hormone on bone Gla protein in GH-deficient adults. J Clin Endocrinol Metab. 70:916-919.
51. Schlemmer A, Johannsen JS, Pedersen SA, Jorgensen JOL, Hassager C, Christiansen C. 1991 The effect of growth hormone therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin Endocrinol (Oxf). 35:471-476.
52. Sartorio A, Conti A, Monzani M, Morabito F, Faglia G. 1993 Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover. J Endocrinol Invest. 16:893-898.
53. Bravenoer N, Lips P, Holzmann P, Blok GJ. 1994 The effect of growth hormone on bone mass and bone turnover of growth hormone deficient men [Abstract B253]. J Bone Miner Res. 9(Suppl 1):9.
54. Vandeweghe M, Taelman P, Kaufman JM. 1993 Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol (Oxf). 39:409-415.
55. Kann P, Piepkorn B, Schehler B, et al. 1995 Replacement therapy with recombinant human growth hormone in GH-deficient adults. Effects on bone metabolism and bone mineral density in a 2-year prospective study. Endocrinol Metab. 2(Suppl B):103-110.
56. Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG. 1994 The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol (Oxf). 40:383-391
57. Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG. 1995 The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clin Endocrinol (Oxf). 42:249-254.
58. Hansen TB, Brixen K, Vahl N, et al. 1996 Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. J Clin Endocrinol Metab. 81:3352-3359.
59. Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM. 1995 Effect of growth hormone replacement on bone mass in adults with adult-onset growth hormone deficiency. Clin Endocrinol (Oxf). 42:627-633.
60. Ter Maaten JC, De Boer H, Roos JC, Lips P, Van der Veen EA. 1997 Long-term effects of growth hormone treatment on bone density [Abstract O-003]. Endocrinol Metab. 4(Suppl A):8.
61. Rosen T, Johannsson G, Bengtsson BA. 1997 Three years of GH treatment in GH-deficient adults increases bone mineral content and density: gender differences [AbstractP-002]. Endocrinol Metab. 4(Suppl A):36.
62. Johannsson G, Rosen T, Bosaeus I, Sjostrom L, Bengtsson BA. 1996 Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab. 81:2865-2873.
63. Bravenboer N, Holzmann P, De Boer H, Lips P. 1997 The effect of growth hormone treatment on bone remodeling in GH-deficient men. Endocrinol Metab. 4(Suppl A):8.
64. Cuneo RC, Salomon F, Wiles CM, et al. 1990 Skeletal muscle performance in adults with growth hormone deficiency Horm Res. 33(Suppl 4):55-60.
65. Rutherford OM, Beshyah SA, Johnston DG. 1994 Quadriceps strength before and after growth hormone replacement in hypopituitary adults: relationship to changes in lean body mass and IGF-I. Endocrinol Metab. 1:41-47.
66. Cuneo RC, Salomon F, Wiles CM, et al. 1991 Growth hormone treatment in growth hormone-deficient adults. I. effects on muscle mass and strength. J Appl Physiol. 70:688-694.
67. Degerblad M, Almkvist O, Grunditz R, et al. 1990 Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol (Copenh). 123:185-913.
68. Jorgensen JOL, Pedersen SA, Thuesen L, et al. 1991 Long-term growth hormone treatment in growth hormone deficient adults. Acta Endocrinol (Copenh). 125:449-453.
69. Cuneo RC, Salomon F, Wiles CM, et al. 1991 Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol. 70:695-700.
70. Nass R, Huber RM, Klauss V, Muller OA, Schopohl J, Strasburger CJ. 1995 Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metab. 80:552-557.
71. Wasserman K, Whipp BJ. 1975 Exercise physiology in health and disease. Am Rev Respir Dis. 112:219-249.
72. Jepson JH, McGary EE. 1972 Hemopoiesis in pituitary dwarfs treated with human growth hormone and testosterone. Blood 39:238-248.
73. Claustres M, Chatelain P, Sultan C. 1987 Insulin-like growth factor-I stimulates human erythroid colony formation. in vitro. J Clin Endocrinol Metab. 65:78-82.
74. Merchav S, Talarsky I, Hochberg Z. 1988 Enhancement of erythropoises in vitro by human growth hormone is mediated by insulin-like growth factor-I. Br J Haematol. 70:267-271.
75. Erfurth EM, Buelow B, Mikozy Z, Nordstroem CH, Hagmar L. 1996 Increased cardiovascular mortality in patients with hypopituitarism. Endocrinol Metab. 3(Suppl A):121.
76. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson B-A. 1993 Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh). 129:195-200.
77. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. 1992 Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 340:1188-1192.
78. Lehmann ED, Hopkins KD, Weissberger AJ, Gosling RG, Sönksen PH. 1993 Aortic distensibility in growth hormone deficient adults. Lancet. 341:309.
79. Johansson JO, Landin K, Tengborn L, Rosen T, Bengtsson B-A. 1994 High tibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler Thromb. 14:434-437.
80. Frustaci A, Perrone GA, Gentiloni N, et al. 1992 Reversible dilated cardiomyopathy due to growth hormone deficiency. Am J Clin Path. 97:503-511.
81. Cuneo RC, Wilmshurst P, Lowy C, et al. 1989 Cardiac failure responding to growth hormone. Lancet. 1:838-39.
82. Cuneo RC, Salomon F, Wilmshurst P, et al. 1991 Cardiovascular effects of growth hormone treatment in growth hormone-deficient adults: stimulation of the renin-aldosterone system. Clin Sci. 81:587-592.
83. Merola B, Cittadini A, Colao A, et al. 1993 Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab. 77:1658-1661.
84. Caidahl K, Eden S, Bengtsson B-Å. 1994 Cardiovascular, and renal effects of growth hormone. Clin Endocrinol (Oxf). 40:393-400.
85. Thuesen L, Jorgensen JOL, Muller JR, et al. 1994 Short and long-term cardiovascular effect of growth hormone therapy in growth hormone deficient adults. Clin Endocrinol (Oxf). 41:615-620.
86. Johannsson G, Bengtsson BA, Andersson B, Isgaard J, Caidahl K. 1996 Long term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients. Clin Endocrinol (Oxf). 45:305-314.
87. Cuocolo A, Nicolai E, Colao A, et al. 1996 Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: assessment with radionuclide angiography. Eur J Nucl Med. 23:390-394.
88. Dunne FP, Elliot P, Gammoge MD, et al. 1995 Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism. Clin Endocrinol (Oxf). 43:623-629.
89. Smallridge RC, Rajfer S, Davia J, Schaaf M. 1979 Acromegaly and the heart. Am J Med. 66:22-27.
90. Hradec J, Marek J, Petrasek J. 1988 The nature of cardiac hypertrophy in acromegaly: an echocardiographic study. Cor Vasa 30:186-199.
91. Morvan D, Komajda M, Grimaldi A, Turpin G, Grosgogeat Y. 1991 Cardiac hypertrophy and function in asymptomatic acromegaly. Eur Heart J. 12:666-672.
92. Wright AD, Hill DM, Lowy C, Fraser TR. 1970 Mortality in acromegaly. Q J Med. 39:1-16.
93. Bengtsson B-Å, Eden S, Ernest I, Oden A, Sjögren B. 1988 Epidemiology and long-term survival in acromegaly. Acta Med Scand. 223:327-335.
94. Cunningham JJ. 1980 A reanalysis of the factors influencing basal metabolic rate in normal adults. Am J Clin Nutr. 33:2372-2374.
95. Ikkos D, Ljunggren H, Luft R. 1956 Basal metabolic rate in relation to body size and cell mass in acromegaly. Acta Endocrinol (Copenh). 21:237-244.
96. O Sullivan AJ, Kelly JJ, Hoffman DM, Freund J, Ho KKY. 1994 Body composition and energy expenditure in acromegaly. J Clin Endocrinol Metab. 78:381-386.
97. Salomon F, Cuneo RC, Umpleby AM, et al. 1994 Interactions of body fat and muscle mass with substrate concentrations and fasting insulin levels in adults with growth hormone deficiency. Clin Sci. 87:201-206.
98. Snel YEM, Doerga ME, Zonderland ML, et al. Resting metabolic rate in growth hormone deficient adults. Proc of the 4th Int Meet on Growth Hormone Deficiency in Adults. 1993; 48.
99. Jorgensen JOL, Moller J, Laursen T, et al. 1994 Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin Endocrinol (Oxf). 41:609-614.
100. Jorgensen JOL, Pedersen SA, Laurberg P, et al. 1989 Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. J Clin Endocrinol Metab. 69:1127-1132.
101. Harant I, Beauville M, Cramps F, et al. 1994 Response of fat cells to growth hormone (GH): effect of long term treatment with recombinant human GH in GH-deficient adults. J Clin Endocrinol Metab. 78:1392-1395.
102. Hussain MA, Schmitz O, Mengel A, et al. 1994 Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J Clin Invest. 94:1126-1133.
103. Jorgensen JOL, Moller J, Alberti KGGM, et al. 1993 Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects. J Clin Endocrinol Metab. 77:1589-1596.
104. Beshyah SA, Sharp PS, Gelding SV, et al. 1993 Whole-body leucine turnover in adults on conventional treatment for hypopituitarism. Acta Endocrinol (Copenh). 129:158-164.
105. Russell-Jones DL, Weissberger AJ, Bowes SB, et al. 1993 The effects of growth hormone on protein metabolism in adult growth hormone deficient patients. Clin Endocrinol (Oxf). 38:427-431.
106. Karnieli E, Laron Z, Richer N, et al. 1993 Insulin resistance in GH-deficient adult patients treated with growth hormone: evidence for a postbinding defect in vivo. In: Laron Z, Butenandt O, eds. Growth hormone replacement therapy in adults: pros and cons. London, Tel Aviv: Freund; 41-49.
107. Fowelin J, Attvall S, Lager I, Bengtsson BA. 1993 Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metab Clin Exp. 42:1443-1447.
108. O'Neal DN, Kalfas A, Dunning PL, et al. 1994 The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. J Clin Endocrinol Metab. 79:975-983.
109. Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA. 1995 Growth hormone-deficient adults are insulin resistant. Metab. Clin Exp. 44:1126-1129.
110. Hew FL, Koschmann M, Christopher M, et al. 1996 Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. J Clin Endocrinol Metab. 81:555-564.
111. DeBoer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA. 1994 Serum lipid levels in growth hormone-deficient men. Metab Clin Exp. 43:199-203.
112. Cuneo RC, Salomon F, Watts GF, Hesp R, Sonksen PH. 1993 Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metab Clin Exp. 42:1519-1523.
113. Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson BA. 1993 Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb. 13:296-301.
114. Russell-Jones DL, Watts GF, Weissberger A, et al. 1994 The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol (Oxf). 41:345-350.
115. Beshyah SA, Henderson A, Niththyananthan R, et al. 1995 The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab. 80:356-363.
116. Weaver JU, Monson JP, Noonan K, et al. 1995 The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab. 80:153-159.
117. Johansson G, Oscarsson J, Rosen T, et al. 1995 Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficients adults. Influence of gender and Apo(a) and Apo(E) phenotypes. Arterioscler Thromb Vasc Biol. 15:2142-2150.
118. Al-Shoumer KAS, Anyaoku V, Gray R, Hughes C, Richmond W, Johnston DG. 1996 Anthropometric and metabolic effects of four years treatment with biosynthetic growth hormone in hypopituitary adults. Endocrinol Metab. 4(Suppl A):53.
119. Garry P, Collins P, Devlin JG. 1996 An open 36 month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. Eur J Endocrinol. 134:61-66.
120. Armstrong VM, Cremer P, Eberle E, et al. 1986 The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 62:249-257.
121. Bostom AG, Cupples LA, Jenner JL, et al. 1996 Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. J Am Med Assoc. 276:544-548.
122. Laron Z, Wang XL, Silbergeld A, Wilcken DEL. Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a). Eur J Endocrinol. In press.
123. Laursen T, Jorgensen JO, Jakobson G, Hansen BL, Christiansen JS. 1995 Continuous infusions vs. daily injections of growth hormone for 4 weeks in GH-deficient patients. J Clin Endocrinol Metab. 80:2410-2418.
124. Angelin B, Rudling M. 1994 Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipidol. 5:160-165.
125. Elam MB, Wilcox HG, Solomon SS, Heimberg M. 1992 In vivo growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated perfused rat liver. Endocrinology 131:2717-2722.
126. Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson JA, Angelin B. 1992 Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA. 89:6983-6987.
127. Cummings MH, Christ E, Umpleby AM, et al. Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency. J Clin Endocrinol Metab. In press.
128. Black MM, Shuster S, Bottoms E. 1972 Skin collagen and thickness in acromegaly and hypopituitarism. Clin Endocrinol (Oxf). 1:259-263.
129. Rudman D, Feller AG, Nagraj HS, et al. 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
130. Lobie PE, Brispohl W, Lincoln DT, et al. 1990 Localization of the growth hormone receptor/binding protein in skin. J Endocrinol. 126:467-472.
131. Pedersen SA, Welling K, Michaelsen KF, et al. 1989 Reduced sweating in adults with growth hormone deficiency. Lancet. 2:681-682.
132. Juul A, Behrenscheer A, Tims T, et al. 1993 Impaired thermoregulation in adults with growth hormone deficiency during heat exposure and exercise. Clin Endocrinol. 38:237-244.
133. Holder A, Spencer EM, Preece MA. 1981 Effect of bovine growth hormone and a partially pure preparation of somatomedin on various growth parameters. J Endocrinol. 89:275-282.
134. Van Buul-Offers S, Ujeda I, Van den Brande JL. 1986 Biosynthestic somatomedin C increases the length and weight of Snell dwarf mice. Pediatric Res. 20:825-877.
135. Ammann AJ, Sherman BM. 1987 Effect of growth hormone therapy on immune function. J Pediatr. 110:663-664.
136. Rongen-Westerlaken C, Rijkers GT, Scholtens EJ, et al. 1991 Immunologic studies in Turner syndrome before and during treatment with growth hormone. J Pediatr. 119:268-272.
137. Wit JM, Kooijman R, Rijkers GT, Zegers BJM. 1993 Immunological findings in growth hormone treated patients. Horm Res. 39:107-110.
138. Saxena GB, Saxena RK, Adler WH. 1982 Regulation of natural killer activity in vivo. III. Effect of hypophysectomy and growth hormone treatment on he natural killer activity of the mouse spleen population. Int Arch Allergy Immunol. 67:169-174.
139. Bozzola M, Valtorta A, Moretta A, Cisternino M, Biscaldi I, Schimpff R. 1990 In vitro and in vivo effect of growth hormone on cytotoxic activity. J Pediatr. 117:596-602.
140. Stabler B, Turner JR, Girdler SS, Light KC, Underwood LE. 1992 Reactivity to stress and psychological adjustment in adults with pituitary insufficiency. Clin Endocrinol (Oxf). 6:467-473.
141. Rosen T, Wiren L, Wilhelmsen L, Wiklund I, Bengtsson BA. 1994 Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol (Oxf). 40:111-116.
142. McGauley GA. 1989 Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Pediatr Scand. 356(Suppl):70-74.
143. Burman P, Broman JE, Hetta J, et al. 1995 Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab. 80:3585-3590.
144. Almqvist O, Thoren M, Sääf, Eriksson O. 1986 Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study. Psychoneuroendocrinology. 11:347-352.
145. Johansson JO, Larson G, Andersson M, et al. 1995 Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology. 61:57-66.
146. Åström C, Lindholm J. 1990 Growth hormone deficient young adults have decreased deep sleep. Neuroendocrinology. 51:82-84.
147. Aström C, Pedersen SA, Lindholm J. 1990 The influence of growth hormone on sleep in adults with growth hormone deficiency. Clin Endocrinol. 33:496-500.
148. Holmes SJ, Shalet SM. 1995 Characteristics of adults who wish to enter a trial of growth hormone replacement. Clin Endocrinol (Oxf). 42:613-618.
149. Holmes SJ, Shalet SM. 1995 Which adults develop side-effects of growth hormone replacement? Clin Endocrinol (Oxf). 43:143-149.
150. Mårdh G, Lundin K, Borg G, Jonsson B, Lindeberg A. 1994 Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled trials. Endocrinol Metab. 1(Suppl A):43-49.
151. Molitch ME. 1992 Clinical manifestations of acromegaly. Clin Endocrinol Metab. 21:597-614.
152. Pickett JBE, Layzer RB, Levin SR, Schneider V, Campbell MJ, Sumner AJ. 1975 Neuromuscular complications of acromegaly. Neurology 25:638-645.
153. Nagulesparen M, Trickey R, Davies MJ, Jenkins JS. 1976 Muscle changes in acromegaly. Br Med J. 2:914-915.
154. Liebermann SA, Björkengren AG, Hoffman AR. 1992 Rheumatologic and skeletal changes in acromegaly. Clin Endocrinol Metab. 21:615-631.
155. Taback SP, Dean HJ. 1996 Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Commitee. J Clin Endocrinol Metab. 81:1693-1696.
156. Moshang Jr T, Rundle AC, Graves DA, Nickas J, Johanson A, Meadows A. 1996 Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience. J Pediatr. 128:S4-S7.
157. Buchanan CR, Preece MA, Milner RD. 1991 Mortality, neoplasia, and Creutzfeld-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. Br Med J. 302:824-828.
158. Blethen SL, Allen DB, Graves D, August G, Moshang T, Rosenfeld R. 1996 Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study Experience. J Clin Endocrinol Metab. 81:1704-1710.
159. Møller J, Jørgensen JOL, Lauersen T, et al. 1993 Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clin Endocrinol (Oxf). 39:403-408.
160. Reaven GM. 1988 Role of insulin resistance in human disease. Diabetes 37:1595-1607.
161. Malozowski S, Tanner LA, Wysowski D, Fleming GA. 1993 Growth hormone, insulin-like growth factor-I, and benign intracranial hypertension N Engl J Med. 329:665-666.
162. Cohn L, Feller AG, Draper MW, Rudman IW, Rudman D. Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations. Clin Endocrinol (Oxf). 39:417-425.
163. Rudman D, Kutner MH, Rogers CM, et al. 1981 Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest. 67:1361-1369.
164. Zadik Z, Chalew SA, McCarter RJ, et al. 1985 The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals J Clin Endocrinol Metab. 60:513-516.
165. Johannsson G, Bjamason R, Bramnert M, et al. 1996 The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J Clin Endocrinol Metab. 81:1575-1581.